Peptide Atlas — health, wellness & peptide resources
Peptide Library
Metabolic Health & Weight Management

5-Amino-1MQ

Also referenced as: 5-amino-1-methylquinolinium, NNMT inhibitor

A small-molecule NNMT inhibitor discussed alongside peptides, with no human evidence base.

Evidence grade
DPreclinical Research

Preclinical Research

Regulatory status
Research Use Only
Human data
No

No registered clinical trials identified

Last reviewed
September 1, 2026

Overview

Despite being grouped with peptides in consumer discussion, 5-Amino-1MQ is a small molecule, not a peptide. It inhibits nicotinamide N-methyltransferase (NNMT), an enzyme involved in NAD+ salvage and adipocyte metabolism.

All meaningful data are preclinical. Marketing language about metabolic transformation is not supported by human research.

Why It's Being Studied

  • NNMT's role in adipose tissue metabolism and NAD+ availability.
  • Whether NNMT inhibition alters fat mass in metabolic disease models.

Mechanism of Action

In plain language

It blocks an enzyme that consumes a molecule cells use for energy metabolism, which in animals shifted how fat cells behaved.

Technical detail

NNMT methylates nicotinamide, diverting it from NAD+ salvage. Inhibition raises intracellular nicotinamide and NAD+ in adipocytes and has been associated in rodent models with reduced adipose tissue mass and altered lipogenic gene expression.

Research Areas & Routes Studied

Areas studied
  • Adipose metabolism
  • NAD+ biology
Routes used in research
  • Oral (in animal research)

Evidence Summary

Rodent and cell studies only. No published human clinical trials were identified at last review.

Animal studies

  • Diet-induced obesity models reported reduced fat mass with NNMT inhibition.

In-vitro studies

  • Adipocyte studies characterised NNMT inhibition and NAD+ changes.

Anecdotal / community information

  • Community claims about weight loss and muscle preservation have no human trial support. No established human dosing protocol exists.

Reported Adverse Events in Research

  • No human safety data. Adverse effects in people are unknown rather than absent.

Limitations of Current Evidence

  • Preclinical only; rodent adipose biology translates unreliably to humans.
  • Product identity and purity in the research-use-only market are frequently undocumented.

Why It Is Used

  • Metabolic Health

    Visceral Fat and Metabolic Markers

    Not weight on a scale, but the fat around the organs — the compartment most strongly tied to metabolic risk.

    Read the case study

Research References

  • Animal study

    Small molecule NNMT inhibition and adipose tissue metabolism

    View Study
This page is an educational research summary. It is not medical advice, does not recommend human use, and does not provide individualised dosing. Many compounds discussed here are research use only and are not approved medicines.